FDA OKs Covidien’s Parietex Optimized Composite for Hernia Repair

The FDA has granted 510(k) clearance and to Parietex Optimized Composite mesh, a new version of the company’s Parietex Composite mesh for open and laparoscopic ventral hernia repair, according to a release by Covidien.

Advertisement

 

The new version incorporates a more resistant barrier and a proprietary textile design with better visibility and increased strength than the original version. The new version is three times more resistant than the original and uses 3-D textile with x-stitch design that is stronger and enables better visibility through the mesh.

 

The original version was introduced in 1999 as the first hernia mesh to offer a resorbable collagen barrier and has been evaluated in over 45 clinical and pre-clinical studies.

 

Read the Covidien release on Parietex.

 

Related Articles on Hernia Repair:

Study: Children Exposed to Brief, Single Anesthetic Show No Long-Term Development Problems

10 Recent Anesthesia Findings and Breakthroughs

5 Recent Findings on Anesthesia in Children

 

 

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.